Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes. Data from the Swedish Heart Failure and Swedish National Diabetes Registries

Overview of attention for article published in European Heart Journal - Cardiovascular Pharmacotherapy, April 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

So far, Altmetric has seen 57 X posts from 42 X users, with an upper bound of 449,478 followers.

RT @pyrpyris: Do 💊GLP-1 Receptor Agonists affect #outcomes in 🫀Heart Failure ❓ ✔️ GLP-1RA led to ⬆️ survival and ⬇️ MACE ✔️ ⬇️ HF hospital…

RT @pyrpyris: Do 💊GLP-1 Receptor Agonists affect #outcomes in 🫀Heart Failure ❓ ✔️ GLP-1RA led to ⬆️ survival and ⬇️ MACE ✔️ ⬇️ HF hospital…

RT @pyrpyris: Do 💊GLP-1 Receptor Agonists affect #outcomes in 🫀Heart Failure ❓ ✔️ GLP-1RA led to ⬆️ survival and ⬇️ MACE ✔️ ⬇️ HF hospital…

RT @pyrpyris: Do 💊GLP-1 Receptor Agonists affect #outcomes in 🫀Heart Failure ❓ ✔️ GLP-1RA led to ⬆️ survival and ⬇️ MACE ✔️ ⬇️ HF hospital…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 53 additional X posts.